Literature DB >> 24099572

Oxford phase 3 unicompartmental knee arthroplasty in Japan--clinical results in greater than one thousand cases over ten years.

Kenjiro Yoshida1, Masahiro Tada, Hirokazu Yoshida, Satoshi Takei, Shinichi Fukuoka, Hiroaki Nakamura.   

Abstract

There are few reports of the Oxford unicompartmental knee arthroplasty (UKA) survival rate in Asia. This study describes outcomes of 1279 Oxford UKAs for Japanese patients. The mean follow-up was 5.2 years. We divided patients into two groups based on preoperative indications (extended indications group and strict indications group). The Oxford knee score improved from 22.3 to 40.8 (P=0.041). The 10-year survival rate using revision was 95%. A total of 25 UKAs (2.0%) required revision. The most common reason was subsidence of tibial component. The 5-year cumulative survival rate of the strict indications group was significantly higher than that of the extended indications group (99.1% vs. 93.8%, P<0.001). When we followed inclusion criteria strictly, good clinical results were achieved in Asia.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Oxford UKA; clinical results; osteoarthritis mobile bearing; unicompartmental knee arthroplasty

Mesh:

Year:  2013        PMID: 24099572     DOI: 10.1016/j.arth.2013.08.019

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  36 in total

1.  Tibial component rotation during the unicompartmental knee arthroplasty: is the anterior superior iliac spine an appropriate landmark?

Authors:  Seung-Yup Lee; Suhwoo Chay; Hong-Chul Lim; Ji-Hoon Bae
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-06-08       Impact factor: 4.342

2.  Up to twelve year follow-up of the Oxford phase three unicompartmental knee replacement in China: seven hundred and eight knees from an independent centre.

Authors:  Huaming Xue; Yihui Tu; Tong Ma; Tao Wen; Tao Yang; Minwei Cai
Journal:  Int Orthop       Date:  2017-05-10       Impact factor: 3.075

3.  Survivorship and patient satisfaction of robotic-assisted medial unicompartmental knee arthroplasty at a minimum two-year follow-up.

Authors:  Andrew D Pearle; Jelle P van der List; Lily Lee; Thomas M Coon; Todd A Borus; Martin W Roche
Journal:  Knee       Date:  2017-02-06       Impact factor: 2.199

4.  [Medial unicondylar knee replacement].

Authors:  O Lorbach; D Pape; P Mosser; D Kohn; K Anagnostakos
Journal:  Orthopade       Date:  2014-10       Impact factor: 1.087

Review 5.  Current state of computer navigation and robotics in unicompartmental and total knee arthroplasty: a systematic review with meta-analysis.

Authors:  Jelle P van der List; Harshvardhan Chawla; Leo Joskowicz; Andrew D Pearle
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-09-06       Impact factor: 4.342

Review 6.  Unicompartmental knee replacement - Current perspectives.

Authors:  Stefano Campi; Saket Tibrewal; Rory Cuthbert; Sheo B Tibrewal
Journal:  J Clin Orthop Trauma       Date:  2017-11-28

7.  Unicompartmental knee arthroplasty is effective: ten year results.

Authors:  Michele Vasso; Chiara Del Regno; Carlo Perisano; Antonio D'Amelio; Katia Corona; Alfredo Schiavone Panni
Journal:  Int Orthop       Date:  2015-07-02       Impact factor: 3.075

Review 8.  [Modern unicondylar knee arthroplasty. Tips and tricks].

Authors:  F von Knoch; U Munzinger
Journal:  Orthopade       Date:  2014-05       Impact factor: 1.087

9.  Five-year experience of cementless Oxford unicompartmental knee replacement.

Authors:  H G Pandit; S Campi; T W Hamilton; O D Dada; S Pollalis; C Jenkins; C A F Dodd; D W Murray
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-11-26       Impact factor: 4.342

10.  Superior femoral component alignment can be achieved with Oxford microplasty instrumentation after minimally invasive unicompartmental knee arthroplasty.

Authors:  Yihui Tu; Huaming Xue; Tong Ma; Tao Wen; Tao Yang; Hui Zhang; Minwei Cai
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-05-25       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.